The investment includes a mix of fresh equity and the conversion of a prior investment made through a Simple Agreement for ...

Sun Pharma invests $25 million in Pharmazz Inc for drug candidates Sovateltide and Centhaquine, with potential licensing ...

Analysts believe that recent product launches in India will further solidify Sun Pharmas leading position in the branded ...

Sun Pharmaceutical , India's largest drugmaker by revenue, reported a bigger adjusted quarterly profit on Thursday, driven by ...

India's equity benchmark indexes opened flat on Friday as losses in Sun Pharmaceutical Industries offset broader gains, amid ...

Sun Pharmaceutical Industries Ltd. closed 14.13% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Shares of Sun Pharmaceutical Industries declined nearly 5% in early trade as its net profit declined in Q4FY25.

The revenue from operations of the pharmacy company has increased by 8.49 per cent to ₹12,815.58 crore, it had reported ...

Sun Pharmaceutical Industries Ltd. closed 12.25% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...